BPG is committed to discovery and dissemination of knowledge
Articles in Press
7/31/2024 8:47:42 AM | Browse: 126 | Download: 8
Category |
Pharmacology & Pharmacy |
Manuscript Type |
Editorial |
Article Title |
Evolving of treatment options for cerebral infarction
|
Manuscript Source |
Invited Manuscript |
All Author List |
Qiong-Yue Cao and Zheng Li |
Funding Agency and Grant Number |
|
Corresponding Author |
Zheng Li, PhD, Lecturer, Pharmacist, Jiangsu Engineering Research Center of Cardiovascular Drugs Targeting Endothelial Cells, College of Health Sciences, School of Life Sciences, Jiangsu Normal University, No. 101 Shanghai Road, Xuzhou 221000, Jiangsu Province, China. lizhengcpu@163.com |
Key Words |
Cerebral infarction; Treatment; Thrombolytic therapy; Aspirin; Edaravone; Natural medicine |
Core Tip |
Over the last few decades, the treatment for cerebral infarction (CI) have undergone a dramatic evolution from pharmacological drugs. This editorial focuses on the progress in treatment options for CI. We hope that this editorial could provide valuable information for the treatment of CI. |
Citation |
<p>Cao QY, Li Z. Evolving of treatment options for cerebral infarction. <i>World J Clin Cases</i> 2024; 12(32): 6534-6537</p> |
 |
Received |
|
2024-06-11 02:33 |
 |
Peer-Review Started |
|
2024-06-11 02:33 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-07-17 21:14 |
 |
Revised |
|
2024-07-26 09:07 |
 |
Second Decision |
|
2024-07-31 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-07-31 08:47 |
 |
Articles in Press |
|
2024-07-31 08:47 |
 |
Publication Fee Transferred |
|
|
 |
Edit the Manuscript by Language Editor |
|
2024-08-06 21:28 |
 |
Typeset the Manuscript |
|
2024-08-23 07:41 |
ISSN |
2307-8960 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
Copyright |
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345